Citi Pharma Limited (PSX:CPHL)

Citi Pharma Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	603.55	87.9	54.61	27.48	3,074
Short-Term Investments	919.59	1,222	1,393	1,660	-
Trading Asset Securities	66.5	108.81	132.36	312.12	-
Cash & Short-Term Investments	1,590	1,418	1,580	2,000	3,074
Cash Growth	12.08%	-10.26%	-20.97%	-34.96%	3337.25%
Accounts Receivable	3,078	2,197	1,882	1,402	444.55
Other Receivables	150.02	203.26	96.29	45.77	-
Receivables	3,228	2,400	1,978	1,447	444.55
Inventory	3,930	3,203	2,609	1,692	778.19
Other Current Assets	723.98	613.03	415.98	458.15	204.08
Total Current Assets	9,472	7,635	6,584	5,597	4,501
Property, Plant & Equipment	8,688	3,530	3,122	2,258	1,735
Long-Term Accounts Receivable	-	-	23.65	-	8.61
Other Long-Term Assets	279.98	274.76	254.54	272.06	254.54
Total Assets	18,439	11,439	9,984	8,127	6,499
Accounts Payable	3,479	3,374	1,938	1,618	993.58
Accrued Expenses	236.33	216.54	206.62	149.67	58.54
Short-Term Debt	2,869	1,437	1,768	521.57	12.2
Current Portion of Long-Term Debt	-	12.86	55.88	160.69	108.71
Current Portion of Leases	15.8	5.42	5.67	4.77	2.99
Current Income Taxes Payable	519.68	470.83	393.19	404.18	126.87
Current Unearned Revenue	-	0.58	3.04	14.51	5.86
Other Current Liabilities	185.89	83.03	82.1	137.28	526.77
Total Current Liabilities	7,305	5,599	4,453	3,010	1,836
Long-Term Debt	-	-	8.54	250.17	189.16
Long-Term Leases	64.86	-	4.37	6.27	7.76
Long-Term Unearned Revenue	-	-	0.58	32.17	9.27
Pension & Post-Retirement Benefits	99.7	82.62	50.34	31.94	14.25
Long-Term Deferred Tax Liabilities	102.07	124.09	94.24	82.3	77.17
Other Long-Term Liabilities	0	-	-	-	-0
Total Liabilities	7,572	5,806	4,611	3,413	2,133
Common Stock	2,285	2,285	2,285	2,285	1,350
Additional Paid-In Capital	1,392	1,392	1,392	1,392	-
Retained Earnings	1,807	1,648	1,388	728.54	380.61
Comprehensive Income & Other	5,385	309.29	309.29	309.29	2,635
Shareholders' Equity	10,868	5,633	5,373	4,714	4,366
Total Liabilities & Equity	18,439	11,439	9,984	8,127	6,499
Total Debt	2,950	1,455	1,843	943.48	320.81
Net Cash (Debt)	-1,360	-36.55	-262.2	1,056	2,754
Net Cash Growth	-	-	-	-61.65%	-
Net Cash Per Share	-5.95	-0.16	-1.15	4.66	14.77
Filing Date Shares Outstanding	228.46	228.46	228.46	228.46	148.5
Total Common Shares Outstanding	228.46	228.46	228.46	228.46	148.5
Working Capital	2,166	2,035	2,131	2,586	2,666
Book Value Per Share	47.57	24.66	23.52	20.63	29.40
Tangible Book Value	10,868	5,633	5,373	4,714	4,366
Tangible Book Value Per Share	47.57	24.66	23.52	20.63	29.40
Land	6,940	1,865	1,865	1,421	1,049
Buildings	673.95	661.56	485.03	309.33	214.96
Machinery	1,758	1,525	1,194	915.01	795.57
Construction In Progress	49.11	130.04	70.39	14.33	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.